Search

everythinglearnresearchcommunity

for

Search:↓

Both injectable contraceptives lower testosterone and SHBG levels, with NET-EN having a greater effect than DMPA-IM.

Blocking the protein CXCL12 with a specific antibody can increase hair growth in common hair loss conditions.

Allergies, especially dust mite allergy, may worsen alopecia areata, and desensitization could help reduce its severity.

Some patients with hair loss after mild COVID-19 had positive tests for certain autoantibodies.

The role of antibodies in alopecia is unclear, but JAK inhibitors show promise for treatment.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

Belatacept may be a promising treatment for alopecia areata.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Gamma/delta T cells help defend skin against heavy metals.

Doctors should consider SLE in males even if antinuclear antibody tests are negative.

The skin can independently form immune responses through special structures, offering new ways to treat skin diseases.

Human hair contains a substance that shows blood group A activity.

Anti-phospholipid antibodies in SLE can cause thrombosis and bone necrosis.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

NK cells play a role in skin diseases like eczema and psoriasis.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

Calancardin B may help reduce inflammation in immune cells.

Removing both KLK5 and KLK7 proteins can prevent death and skin issues in Netherton syndrome.

IVIg treatment improved symptoms but caused permanent dark hair loss.

IVIG and dupilumab effectively improved symptoms in a child with Netherton syndrome.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

Alopecia areata patients have fewer protective regulatory B cells, which may contribute to the disease.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Allergic reactions to blood thinners are rare but can be serious, requiring careful testing and alternative treatments.

Clq deficiency is linked to systemic lupus erythematosus symptoms.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

The conclusion suggests that the zinc lozenge study is valid despite imperfect blinding, as many participants could not correctly identify their lozenge type.